Bayer AG
XETRA:BAYN
Bayer AG
Total Receivables
Bayer AG
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Total Receivables
€12.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Total Receivables
$4.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Total Receivables
€4.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
MPH Health Care AG
XETRA:93M1
|
Total Receivables
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Total Receivables
€91.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Total Receivables
€8.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Total Receivables?
Total Receivables
12.8B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Total Receivables amounts to 12.8B EUR.
What is Bayer AG's Total Receivables growth rate?
Total Receivables CAGR 10Y
3%
Over the last year, the Total Receivables growth was -7%. The average annual Total Receivables growth rates for Bayer AG have been 1% over the past three years , -2% over the past five years , and 3% over the past ten years .